The implantable infusion pump: A new concept in drug delivery

P. J. Blackshear, T. D. Rohde, F. Prosl, Henry Buchwald

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


Several of our most useful drugs cannot be administered orally. This paper is a summary of our work with a new drug delivery system: a totally implantable, continuous infusion pump, with a self-contained inexhaustible power source. Currently, after bench tests and animals experimentation, we have initiated clinical series utilizing this device to treat individuals with refractory thromboembolic conditions by intravenous heparin, and patients with localized solid tumors by intra-arterial chemotherapy. The use of this device for the infusion of insulin in the management of diabetes mellitus is yet in the laboratory stage of development. In addition to improving day-to-day diabetic control and obviating the need for daily insulin injections, this pump offers an ideal opportunity to test whether optimal blood glucose control can significantly prevent or delay the onset of the crippling vascular complications of diabetes. The potential uses of this device, in many fields, are myriad.

Original languageEnglish (US)
Pages (from-to)149-161
Number of pages13
JournalMedical Progress through Technology
Issue number4
StatePublished - Dec 1 1979


Dive into the research topics of 'The implantable infusion pump: A new concept in drug delivery'. Together they form a unique fingerprint.

Cite this